New York
T:
+1 212 848 4843
F:
+1 646 848 4843
Add to Outlook
|
Beau
W.
Buffier
Partner
Education
New York University School of Law, (Trade Regulation), LL.M.
University of Sydney, LL.B. (Hons)
University of Sydney, B.A. Econ
Practice
Beau Buffier is a partner in the New York office and Co-Head of Shearman & Sterling’s Global Antitrust Group. His practice focuses on defending mergers and acquisitions before the Federal Trade Commission, Department of Justice, and various foreign competition authorities. Mr. Buffier also represents domestic and foreign clients in connection with various antitrust issues concerning cartel matters, litigation, counseling, joint ventures, distribution arrangements, intellectual property, competitor collaborations and Hart-Scott-Rodino compliance. Mr. Buffier has defended substantive merger investigations and other civil and criminal investigations involving a wide variety of industries, including pharmaceuticals, medical devices and equipment, crop protection, semiconductors, software, wood products, chemicals, music, film, finance and telecommunications. Prior to joining Shearman & Sterling, Mr. Buffier was an associate in the competition group at Mallesons Stephen Jaques in Sydney.
Experience
-
Fujifilm Holdings Corporation in its pending acquisition of SonoSite, Inc.
-
An Asia-based industrial company in a major non-public cartel investigation by the U.S. Department of Justice and other antitrust agencies
-
A major multinational financial services company in a cartel investigation by the U.S. Department of Justice
-
EQT/Investor in the $2.6 billion sale of CaridianBCT to Terumo Corporation
-
Boston Scientific in the $1.5 billion sale of its Neurovascular Business to Stryker Corporation
-
Sybase in its $5.8 billion sale to SAP America
-
HeartWare International, Inc. in its proposed acquisition by Thoratec Corporation
-
Corning Incorporated in its acquisition of Axygen BioScience, Inc.
-
SunCor Energy, Inc. in its $15.8 billion acquisition of Petro-Canada
-
B/E Aerospace in its acquisition of Honeywell’s Aerospace Consumables business and its acquisition of TSI Group, Inc.
-
Thomson in its acquisition of Reuters Group PLC, its acquisition of Information Holdings Inc and the sale of its Thomson Learning, Prometric and Skillsoft businesses
-
ST Micro in the formation of a $3.1 billion flash-memory joint venture with Intel, its acquisition of Genesys Microchip and its $1.27 billion sale of Numonyx Holding B.V. to Micron Technology
-
ATI Technologies in its acquisition by Advanced Micro Devices
-
Paramount Pictures Corporation in its acquisition of DreamWorks SKG
-
Citigroup in its acquisition of Old Lane Partners
-
Novartis in the sale of its medical nutrition business to Nestle
-
BASF AG in its acquisition of Johnson Polymer and its acquisition of Degussa Construction Chemicals
-
Continental AG in its acquisition of Motorola’s automotive electronics business
-
Gambro in the sale of its U.S. dialysis clinics to DaVita Inc. and in its worldwide hemodialysis distribution agreement with Baxter
-
Novartis in its acquisition of the consumer health business of Bristol Myers Squibb
-
Aventis in the sale of its worldwide crop protection business to Bayer
-
Legg Mason in its acquisition of Citigroup’s asset management business and the simultaneous sale to Citigroup of its broker-dealer business
-
Société Générale in its joint venture with Crédit Agricole and the creation of the Amundi Group through the combination of their worldwide asset management operations
-
Votorantim in its acquisition of Aracruz Cellulose, its sale of Alellyx to Monsanto, and in its acquisition of several cement plants from Cemex
-
Thomson Reuters in connection with a European Commission Art. 102 investigation
-
Rhodia in connection with disputes with INVISTA related to nylon intermediates
-
Defending INO Therapeutics in several antitrust counterclaims brought against it in its patent litigation with Sensormedics and Pulmonox
-
Syngenta in its antitrust suit against Monsanto Company alleging unlawful monopolization in various markets relating to the genetic modification of corn plants
Selected Professional & Business Activities
Publications & Presentations
-
Shoot First, Ask Questions Later: The Regulation of Competition in Telecommunications Markets in Australia, 10 TPLJ 5 (2002)
-
When Clearance is not Enough: Complainants, Litigation and Implications for the Merger Process, British Institute of International and Comparative Law, 5th Annual Merger Conference, Nov. 24, 2006
-
Antitrust and M&A Transactions, Are there any Hot Topics?, ABA Business Law Section Spring Meeting, Ma. 17, 2007
-
US Merger Control: The Hart-Scott-Rodino Act and Practical Insights into the DOJ/FTC Regulatory Reviews, Presentation to JP Morgan Cazenove, Apr. 4, 2008
-
Antitrust and Intellectual Property: the U.S. Experience, 6to Seminario Internacional de Competencia Economica, Mexico City, Nov. 11, 2008
-
Don’t Go Breaking My Heart: The FTC’s Decision to Block Thoratec Corporation’s Proposed Acquisition of HeartWare International, Inc., The Threshold, Fall 2009
-
Strategic Deals Require Strategic Thinking: Antitrust Provisions to Consider in Negotiated Transactions, M&A Lawyer, February 2010 (with Peter D. Lyons and Jessica K. Delbaum)
-
Down, But Not Yet Out: The Continuing Importance of Market Definition in Merger Cases, GCR Antitrust Law Leaders’ Forum, Miami, Feb. 14, 2011
Bar Admissions/Qualifications
New York
New South Wales, Australia
Solicitor, England and Wales
|